TriangleNCT00530088 · OUTCOME
Local Toxicity
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- 30 days
What was measured
Number of patients with an adverse event
Analysis population: All treated and eligible patients
Groups in this outcome
Porfimer Sodium
Patients receive porfimer sodium subcutaneously followed by photodynamic therapy (PDT) comprising laser light delivered by a single or a diffuser (i.e., for broad areas of dysplasia) fiberoptic lens fiber. porfimer sodium: IV
| Group | Source count |
|---|---|
| Porfimer Sodium | 30 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Porfimer Sodium | 29 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 29
- denoms
- counts
- group Id
- OG000
- value
- 30
- units
- Participants
- description
- Number of patients with an adverse event
- groups
- description
- Patients receive porfimer sodium subcutaneously followed by photodynamic therapy (PDT) comprising laser light delivered by a single or a diffuser (i.e., for broad areas of dysplasia) fiberoptic lens fiber. porfimer sodium: IV
- id
- OG000
- title
- Porfimer Sodium
- param Type
- NUMBER
- population Description
- All treated and eligible patients
- reporting Status
- POSTED
- time Frame
- 30 days
- title
- Local Toxicity
- type
- PRIMARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice